GHUCCTS

News

Share This
  • June 15, 2020

NIH announces RADx-UP initiative to improve COVID-19 testing for underserved and vulnerable populations

The National Institutes of Health (NIH) has launched an unprecedented four-pronged initiative, entitled Rapid Acceleration of Diagnostics, or RADx, to catalyze the scientific community to improve testing technologies, capacity, and accessibility for the country. As one of the four RADx components, RADx-Underserved Populations (RADx-UP) will establish a network of community-engaged projects to improve access to and acceptance of testing in underserved and vulnerable populations. The overarching goal of this $500M effort is to understand factors that have led to disproportionate burden of the pandemic on these populations, so that interventions can be implemented to decrease the disparities.

As part of the RADx-UP initiative, NIH has released four funding opportunities to solicit community-engaged research on COVID-19 testing among underserved and/or vulnerable populations to both understand and close the disparity gap. These funding opportunities include:

  1. Emergency competitive revision applications to existing awards for large consortia, multi-site trials, centers and other current networks that have adequate capacity, infrastructure, and established community-engaged relationships to support large-scale testing interventions or have the capacity to ramp up quickly to reach underserved or vulnerable populations. (NOT-OD-20-121)

  2. Complementary emergency competitive revision opportunity which shifts eligibility to collaborative and individual research awards, generally focused on smaller underserved or vulnerable populations. (NOT-OD-20-120)

  3. Emergency competitive revisions to solicit research to understand the social, ethical, and behavioral implications (SEBI) of COVID-19 testing in these populations. (NOT-OD-20-119)

  4. A new Coordination and Data Collection Center (CDCC) award (U24), a key component of the consortium. The CDCC will serve as a national resource, working with NIH scientific staff and consortium members to provide overarching support and guidance in the following four domains: (1) Administrative Operations and Logistics, (2) COVID-19 Testing Technology, (3) Community and Health System Engagement and (4) Data Collection, Integration and Sharing. (RFA-OD-20-013)

Applications for this first phase will be accepted through August 2020. A second phase will be staggered to provide flexibility and to allow for adaption to the ever-changing needs that may be present as this pandemic evolves. 

Please email ghuccts@georgetown.edu if you are interested in collaborating on an application for these awards.

Related News

Register today for the GHUCCTS 2020-2021 Grant Writing Workshop Series

Sep 11, 2020

The Georgetown-Howard Universities Center for Clinical and Translational Science is offering a 6 month Grant Writing Workshop Series for predoctoral students and postdoctoral fellows, and junior faculty who are actively working on individual fellowship, career development, and research project grant application that is due within the next 12 months. The workshops are embedded within our Translational Biomedical Science (TBS) evening workshops series on Thursdays from 5:30-7:30pm via Zoom.

GHUCCTS KL2 scholar alumna Dr. Seble Kassaye leads development of confidential COVID-19 symptom tracking tool

Aug 17, 2020

Dr. Seble Kassaye, associate professor of medicine at Georgetown University Medical Center and former GHUCCTS KL2 scholar, led a team of researchers to develop an online COVID-19 symptom tracking tool. The tool ensures a person’s confidentiality while being able to actively monitor their symptoms. The tool is not proprietary and can be used by entities that are not able to develop their own tracking systems..

GHUCCTS team members discuss clinical trial participation among African Americans with radio and news outlets

Aug 06, 2020

GHUCCTS Community Engagement (CE) team members Dr. Carla Williams and Florencia Gonzalez speak with the Center for Health Journalism at USC and Howard University Radio WHUR 96.3 about the importance of diversity in clinical trials, especially relating to COVID-19. 

Close